Status: Recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
This clinical trial studies the effects of dexrazoxane hydrochloride on biomarkers associated with cardiomyopathy and heart failure after cancer treatment. Studying samples of blood in the laboratory from patients receiving dexrazoxane hydrochloride may help doctors learn more about the effects of dexrazoxane hydrochloride on cells. It may also help doctors understand how well patients respond to treatment.
Participants needed: 420
Trial details
Biological sex: AllType: ObservationalSponsor: Children's Oncology GroupUpdated: May 18, 2026Locations: 79
Eligibility criteria
STRATUM I AND STRATUM II: LEUKEMIA AND LYMPHOMA SURVIVORS [+10]
Newly diagnosed, previously untreated biopsy-proven moderate or high grade osteo... [+14]